Dr. David Shafer, Chief Medical Technology Officer for Aquavit Pharmaceuticals, was recently quoted in a press release about a licensing agreement with a new microneedle device technology. “It is an innovative delivery system for botulinum toxins and dermal fillers. I use it with Botox, hyaluronic acid-based fillers and vitamin combinations”. You can read the full press release here.